Anti-CCP Fast Test Kit (lmmunofluorescence Assay)

>RF Fast Test Kit  (Immunofluorescence Assay)   Intended Use RF Fast Test Kit (Immunofluorescence Assay) is intended for in vitro quantitative determination of rheumatoid factor (RF) in serum, plasma or whole blood samples. The test is designed to aid in the diagnosis of autoimmune diseases, such as rheumatoid arthritis (RA).   About RF Rheumatoid factor is an autoantibody targeting the Fc fragment of human or animal denatured IgG molecule. RF mainly includes four types of IgM, IgG, IgA and IgE. IgM is the main type of RF, and this test kit mainly detects this type.   Specification   Test Item Sample Type Method Storage Condition RF S/P/WB Immunofluorescence Assay 4-30℃ Detection Range Test Time Cut-off Value Shelf Life 10.0-640.0 IU/mL 10 min 15.9 IU/mL 24 months   Applicable Device   Getein 1100 Immunofluorescence Quantitative Analyzer Getein 1160 Immunofluorescence Quantitative Analyzer Getein 1180 Immunofluorescence Quantitative Analyzer Getein 1200 Immunofluorescence Quantitative Analyzer Getein 1600 Immunofluorescence Quantitative Analyzer    

>ASO Fast Test Kit  (Immunofluorescence Assay)   Intended Use ASO Fast Test Kit (Immunofluorescence Assay) is intended for in vitro quantitative determination of anti streptolysin "O" antibody (ASO) in serum, plasma or whole blood samples. ASO is a very valuable marker for the diagnosis of group A streptococcal infection, its titer can reflect the severity of infection. Some diseases will lead to a significant increase in ASO titer, such as wind damp heat, acute glomerulonephritis, nodular erythema, scarlet fever, acute tonsillitis.   About ASO Streptolysin "O", a protein with hemolytic activity, is one of the important metabolites of group A streptococcus. It can dissolve the red blood cells of human and some animals. Streptolysin "O" has strong antigenicity. When human is infected with group A hemolytic streptococcus, B lymphocytes will secrete corresponding antibodies under the stimulation of streptolysin "O", that is, anti streptolysin "O" (ASO). This antibody can neutralize streptolysin "O" and disable its hemolytic ability. ASO began to rise one week after group A Streptococcus infection, peaked in 4-5 weeks and lasted for several months.As the infection subsides, ASO decreased and returned to normal value within 6 months. The disease condition can be judged by repeated measurements over time. The increase of ASO over time indicates the early stage of infection, decrease indicates the subside stage of infection. The lack of decline in ASO titer suggested the possibility of recurrent or chronic infection.   Specification   Test Item Sample Type Method Storage Condition ASO S/P/WB Immunofluorescence Assay 4-30℃ Detection Range Test Time Cut-off Value Shelf Life 60.0-1370.0 IU/mL 10 min 400.0 IU/mL 24 months   Applicable Device   Getein 1100 Immunofluorescence Quantitative Analyzer Getein 1160 Immunofluorescence Quantitative Analyzer Getein 1180 Immunofluorescence Quantitative Analyzer Getein 1200 Immunofluorescence Quantitative Analyzer Getein 1600 Immunofluorescence Quantitative Analyzer    

>fT3 Fast Test Kit is used as an aid in clinical routine diagnostics for the assessment of the thyroid status.

>Getein Anti-HCV Fast Test Kit is used as an aid in the clinical diagnosis, prognosis and evaluation of hepatitis C.  

>Getein 1100 Vet is a compact and semi-automated POCT analyzer that can be used as an aid in clinical diagnostics for pets.

>Getein 208 is intended to detect and quantify specific chemical components in human blood serum, plasma, whole blood, capillary blood, and urine samples through Dry Chemistry and Fluorescence Immunoassay.    

>Getein BHA-5100, available in the Metis 600 Modular System, meets the clinical requirements and exceeds your expectations!

>Getein TnT Fast Test Kit is used as an aid for the early screening of acute myocardial infarction (AMI), heart failure, unstable angina pectoris, myocarditis and other myocardial injuries, it can also be used for the assessment of prognosis and risk stratification of acute pulmonary embolism and the monitoring of myocardial injury in thoracic surgery.